Your browser doesn't support javascript.
loading
Oncofetal reprogramming in tumour development and progression.
Sharma, Ankur; Blériot, Camille; Currenti, Jennifer; Ginhoux, Florent.
Afiliação
  • Sharma A; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia, Australia. ankur.sharma@perkins.org.au.
  • Blériot C; Curtin Medical School, Curtin University, Bentley, Western Australia, Australia. ankur.sharma@perkins.org.au.
  • Currenti J; Curtin Health Innovation Research Institute, Curtin University, Bentley, Western Australia, Australia. ankur.sharma@perkins.org.au.
  • Ginhoux F; Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. ankur.sharma@perkins.org.au.
Nat Rev Cancer ; 22(10): 593-602, 2022 10.
Article em En | MEDLINE | ID: mdl-35999292
Embryonic development is characterized by rapidly dividing cells, cellular plasticity and a highly vascular microenvironment. These features are similar to those of tumour tissue, in that malignant cells are characterized by their ability to proliferate and exhibit cellular plasticity. The tumour microenvironment also often includes immunosuppressive features. Reciprocal communication between various cellular subpopulations enables fetal and tumour tissues to proliferate, migrate and escape immune responses. Fetal-like reprogramming has been demonstrated in the tumour microenvironment, indicating extraordinary cellular plasticity and bringing an additional layer of cellular heterogeneity. More importantly, some of these features are also present during inflammation. This Perspective discusses the similarity between embryogenesis, inflammation and tumorigenesis, and describes the mechanisms of oncofetal reprogramming that enable tumour cells to escape from immune responses, promoting tumour growth and metastasis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Nat Rev Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Nat Rev Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália